CFTR and cystic fibrosis: In our study in a cohort of 12 patients, the assessment of functional correction by the CFTR biomarkers SCC and ICM showed for the first time that LUM/IVA therapy results in consistent partial rescue of CFTR function in different organs in children with CF who are F/F between the ages of 2 and 11 years (Figures 2A–D).